CONTRAST MEDIA REDUCE CSF PRODUCTION MECHANISM/TOXICITY
CONTRAST MEDIA REDUCE CSF PRODUCTION MECHANISM/TOXICITY
批准号:
3179662
负责人:
Phillip Harnish
金额:
$11.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1989-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The causes of the adverse responses to contrast media (CM) are not well
understood but may involve CM-induced alterations of the central nervous
system (CNS). The blood brain barrier (BBB) strictly controls access of
substance to the CNS. The rate of cerebrospinal fluid (CSF) production is
a key factor in eliminating substances from the CNS. These two factors
thus maintain and control the chemical environment of the CNS. If either
factor is disrupted, toxic manifestations could occur. Both factors can be
altered by CM. Contrast media are up to several hundred times more toxic
in the CNS than systemically, and are able to disrupt the BBB. Experiments
in dogs from this laboratory show that moderate doses of both ionic and
non-ionic intravenous CM substantially decrease CSF production. Therefore,
CM might be expected to alter the environment of the CNS and result in
toxicity. The mechanisms of CM effects on the production of CSF will be
studied in the proposed work. Conscious and anesthetized laboratory animal
models and in vitro preparations will be employed to determine: the
mechanisms of CM-induced ecreased CSF production; the extent of CNS
toxicity resulting from this action of CM; changes in the concentration,
retention and kinetics of substances in the CNS caused by CM; enhancement
by certain risk factors of CM-induced toxicity by additionally decreasing
CSF production or by predisposing the BBB to damaging effects of CM; and if
it is possible to protect from these effects of CM pharmacologically.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
1988
期刊:
Acta radiologica (Stockholm, Sweden : 1987)
影响因子:
--
作者:
[Harnish,PP, Zuniga,J, Northington,FK, Melrose,PA, Joseph,SA, Kido,DK, Knigge,KM]
通讯作者:
Knigge,KM
Diatrizoate levels in cerebrospinal fluid following intravenous administration. Role of fluid production rate.
静脉注射后脑脊液中泛影酸盐的水平。
DOI:
10.1097/00004424-198805000-00009
发表时间:
1988
期刊:
Investigative radiology
影响因子:
6.7
作者:
[Harnish,PP, Northington,FK, Samuel,KA]
通讯作者:
Samuel,KA
Opiate involvement in contrast media-induced blood pressure changes.
阿片类药物参与造影剂引起的血压变化。
DOI:
10.1097/00004424-198711000-00012
发表时间:
1987
期刊:
Investigative radiology
影响因子:
6.7
作者:
[Harnish,PP, Mukherji,M, Northington,FK, Kido,DK]
通讯作者:
Kido,DK
Intravascular contrast media and the blood-brain barrier. Testing the new nonionic agent ioxilan.
血管内造影剂和血脑屏障。
DOI:
10.1097/00004424-198901000-00009
发表时间:
1989
期刊:
Investigative radiology
影响因子:
6.7
作者:
[Harnish,PP, Krutchen,A, Mukherji,M]
通讯作者:
Mukherji,M
Physiologic effects of contrast media in the rabbit.
对比剂对兔子的生理影响。
DOI:
10.1097/00004424-198711000-00011
发表时间:
1987
期刊:
Investigative radiology
影响因子:
6.7
作者:
[Harnish,P, Mukherji,M, Kido,DK]
通讯作者:
Kido,DK
共 8 条
EVP-ABD: AN IMPROVED LIVER SPECIFIC AGENT FOR MRI
-
批准号:6209545
-
项目类别:
-
资助金额:$10.59万
-
财政年份:2000
-
负责人:Phillip Harnish
-
依托单位:
EVP-ABD for MRI of Liver Disease
-
批准号:6548823
-
项目类别:
-
资助金额:$49.1万
-
财政年份:2000
-
负责人:Phillip Harnish
-
依托单位:
EVP-ABD for MRI of Liver Disease
-
批准号:6644214
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2000
-
负责人:Phillip Harnish
-
依托单位:
'MAGNETIC THALLIUM' FOR MRI OF ISCHEMIC HEART DISEASE
-
批准号:6499009
-
项目类别:
-
资助金额:$37.34万
-
财政年份:1999
-
负责人:Phillip Harnish
-
依托单位:
'MAGNETIC THALLIUM' FOR MRI OF ISCHEMIC HEART DISEASE
-
批准号:6294872
-
项目类别:
-
资助金额:$37.67万
-
财政年份:1999
-
负责人:Phillip Harnish
-
依托单位:
MAGNETIC THALLIUM FOR MRI OF ISCHEMIC HEART DISEASE
-
批准号:6014994
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1999
-
负责人:Phillip Harnish
-
依托单位:
CONTRAST MEDIA REDUCE CSF PRODUCTION MECHANISM/TOXICITY
-
批准号:3179659
-
项目类别:
-
资助金额:$12.08万
-
财政年份:1985
-
负责人:Phillip Harnish
-
依托单位:
CONTRAST MEDIA REDUCE CSF PRODUCTION MECHANISM/TOXICITY
-
批准号:3179661
-
项目类别:
-
资助金额:$8.77万
-
财政年份:1985
-
负责人:Phillip Harnish
-
依托单位:
海外基金